Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PLAN-A TERAPI- OG KURSUSCENTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.1% 1.1% 2.5% 0.9% 0.8% 1.0% 11.9% 11.9%   Credit score (0-100)   69 85 62 88 91 85 20 20   Credit rating   A A BBB A AA A BB BB   Credit limit (kDKK)   0.2 160.3 0.0 603.5 715.1 450.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,138 13,320 14,740 19,710 20,435 20,682 0.0 0.0   EBITDA   1,109 1,719 1,162 3,916 3,230 3,061 0.0 0.0   EBIT   1,082 950 62.8 2,775 2,239 2,071 0.0 0.0   Pre-tax profit (PTP)   1,059.8 826.2 -69.7 2,685.0 2,194.9 2,006.6 0.0 0.0   Net earnings   823.7 640.3 -60.8 2,256.1 1,704.2 1,555.6 0.0 0.0   Pre-tax profit without non-rec. items   1,060 826 -69.7 2,685 2,195 2,007 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,093 3,886 3,024 3,028 1,600 761 0.0 0.0   Shareholders equity total   587 1,227 433 2,689 2,493 2,931 1,684 1,684   Interest-bearing liabilities   1,629 3,640 3,423 1,355 1,364 37.0 0.0 0.0   Balance sheet total (assets)   3,763 6,551 7,116 7,163 6,649 5,895 1,684 1,684   Net Debt   1,265 3,430 3,374 178 -629 -559 -1,684 -1,684     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,138 13,320 14,740 19,710 20,435 20,682 0.0 0.0   Gross profit growth   22.6% 86.6% 10.7% 33.7% 3.7% 1.2% -100.0% 0.0%   Employees   10 21 26 29 30 32 0 0   Employee growth %   21.8% 99.4% 25.5% 10.7% 4.5% 6.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,763 6,551 7,116 7,163 6,649 5,895 1,684 1,684   Balance sheet change%   87.9% 74.1% 8.6% 0.7% -7.2% -11.3% -71.4% 0.0%   Added value   1,109.1 1,718.6 1,162.1 3,916.2 3,380.6 3,060.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,048 1,024 -1,962 -1,137 -2,419 -1,829 -761 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.2% 7.1% 0.4% 14.1% 11.0% 10.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.5% 18.4% 0.9% 38.9% 32.9% 33.6% 0.0% 0.0%   ROI %   61.4% 25.8% 1.3% 56.3% 46.5% 48.6% 0.0% 0.0%   ROE %   92.0% 70.6% -7.3% 144.5% 65.8% 57.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   15.6% 18.7% 6.1% 37.5% 37.5% 49.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   114.1% 199.6% 290.3% 4.5% -19.5% -18.3% 0.0% 0.0%   Gearing %   277.4% 296.5% 790.7% 50.4% 54.7% 1.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.7% 4.7% 3.8% 3.8% 5.5% 14.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.4 1.6 1.0 1.4 2.3 0.0 0.0   Current Ratio   0.9 1.4 1.6 1.0 1.4 2.3 0.0 0.0   Cash and cash equivalent   363.3 210.1 49.1 1,177.2 1,992.3 595.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -213.0 650.1 1,319.5 145.2 1,338.2 2,621.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   107 83 45 136 112 96 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   107 83 45 136 107 96 0 0   EBIT / employee   104 46 2 96 74 65 0 0   Net earnings / employee   79 31 -2 78 57 49 0 0